Deborah Cooper

An independent candidate proposes a $50,000 graduate dividend, funded by redirecting billions in offshore pension wealth to tackle youth disenfranchisement.

Auto parts giant LKQ Corporation explores a potential sale after 2025 profits fall, despite strong cash flow and a new restructuring plan.

ICANN's 2026 domain expansion offers Turkish firms a rare chance to claim new digital real estate. But is the opportunity worth the significant cost?

As Teladoc faces slowing growth, the virtual care giant adds insurance titan Michael Smith to its board, signaling a push for financial discipline.

With a high-yield but unstable dividend, Brandywine's Q1 earnings will reveal its strategy for navigating the challenging urban office market.

A groundbreaking, NIH-funded trial will use advanced PET imaging to test new Alzheimer's drugs, with XingImaging managing the critical visual data.

With a new President known for scaling iconic brands, Carbone Fine Food signals an aggressive push for leadership in the premium grocery space.

A breakthrough cell line shows a two-fold increase in viral vector quality, a key step in making gene therapies more effective, safer, and accessible.

As Ottawa commits $81.8B to defence, Volatus Aerospace positions itself to spearhead sovereign drone capabilities with a new strategic industrial plan.

A new AI shopping agent powered by 20 years of data promises to end sizing guesswork. Can it solve e-commerce's most expensive problem for good?

Plano-based Ziosk's 2025 Top Workplace award highlights how a focus on employee engagement is a key ingredient for success in the competitive tech industry.

A key Medtrade 2026 panel led by Synapse Health will unite industry leaders to chart the future of value-based care in the DME market.

Amid soaring metal prices and economic fears, a new ranking spotlights top performers. A micro-cap stock is up 300%, signaling a new gold rush for investors.

As Xtract One readies its Q2 results, investors eye its booming backlog against a backdrop of rising competition and ethical questions in AI security.

Fresh off a $1.1B IPO and a #1 GreenTech ranking, BETA Technologies faces investors to prove its electric aviation vision is commercially viable.

Warner Bros. Discovery pushes for a Netflix merger but opens a one-week window for Paramount Skydance to fix its flawed bid. A bidding war looms.

Oculis appoints former Cooley partner Katie Kazem as CLO, a strategic move to fortify governance ahead of pivotal data readouts for its late-stage eye drugs.

Beijing's X-Humanoid launches its new Tien Kung 3.0 robot, aiming to break down industry barriers with a powerful open-source AI and hardware platform.

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

A world-first quantum teleportation over commercial fiber proves a secure, unhackable internet is closer than ever, thanks to a Canadian tech partnership.